8:33 am Zogenix: Data from Zohydro ER Phase 3 clinical trial published in pain medicine demonstrates its benefit as a therapeutic option for the management of pain; The 801 efficacy study in subjects with chronic low back pain met the prima – HedgeChatter

8:33 am Zogenix: Data from Zohydro ER Phase 3 clinical trial published in pain medicine demonstrates its benefit as a therapeutic option for the management of pain; The 801 efficacy study in subjects with chronic low back pain met the prima

13 Feb

8:33 am Zogenix: Data from Zohydro ER Phase 3 clinical trial published in pain medicine demonstrates its benefit as a therapeutic option for the management of pain; The 801 efficacy study in subjects with chronic low back pain met the prima

Bystocknews stock, ZGNX Comments Off

View todays social media effects on ZGNX

View the latest stocks trending across Twitter. Click to view dashboard

See who Zogenix is hiring next, click here to view

Author